Hytrin, generically known as terazosin, is a medication primarily used in the management of hypertension (high blood pressure) and the treatment of symptoms associated with benign prostatic hyperplasia (BPH), which is an enlarged prostate. It belongs to a class of drugs known as alpha-blockers, which work by relaxing the muscles in the blood vessels and the prostate, allowing for easier blood flow and reducing the symptoms of BPH such as difficulty in starting urination, weak stream, and the need to urinate frequently or urgently. Hytrin is taken orally, and its dosage may vary depending on the condition being treated, the severity of symptoms, and the patient's response to the medication. It is important for patients to follow their healthcare provider's instructions closely when taking Hytrin to ensure its effectiveness and to minimize potential side effects.